Justera Launches Premium Laser Treatment with CUTERA XEO

Toronto, Ontario–(Newsfile Corp. – November 8, 2023) – Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company“) is pleased to announce that the Company’s wholly-owned subsidiary, Juillet Wellness Centre, (“Juillet Wellness“), has launched an extended range of premium laser treatment services with CUTERA XEO (“XEO“). XEO is manufactured by one of the industry leaders, Cutera Face and Body Aesthetic Solutions (“CUTERA“) brings a new dimension to non-surgical aesthetic treatments.

With the addition of XEO, Juillet Wellness now offers the following premium laser treatments:

1. IPL Treatment: harnesses the gentle power of Intense Pulsed Light to address various skin concerns, promoting a more even complexion and reducing signs of sun damage.
2. Genesis Treatment: promotes collagen production, naturally reducing fine lines and wrinkles.
3. Nd-YAG Laser Treatment: targets specific skin issues such as vascular lesions and unwanted hair with the precision of Nd-YAG laser technology, ensuring comfortable and effective outcomes.

“Embracing innovation, we’re excited to introduce XEO at Juillet Wellness Centre. CUTERA XEO technology signifies our ongoing commitment to exceptional care. With XEO, we’re offering our clients advanced treatments that enhance natural beauty and confidence. It’s a significant step forward in our mission to redefine beauty and wellness experiences,” said Edward Park, Chief Executive Officer of the Company.

About XEO

XEO is a premium laser platform designed for skin revitalization and resurfacing, pigmented lesions, vascular lesions and hair removal. It is a customizable, multi-application laser, and light-based platform designed to treat the widest range of today’s most common nonsurgical aesthetic concerns. Applications include acne scars, age spots, angiomas, compromised skin, deep dermal heating, freckles, inflammatory active acne, hair removal, lentigines, photodamage, poikiloderma, rosacea, scar reduction, facial veins, leg veins, periorbital veins, venous lakes, warts, wrinkles and more.

To learn more, please visit: https://www.cutera.com/solutions/xeo/.

About CUTERA

Cutera was founded in 1998 by veteran laser and optical engineers with a vision of offering the best solutions for achieving superior outcomes in the next frontier of medical aesthetics. Cutera aims to define the leading medical aesthetics with devices that appeal to forward-thinking clinicians who need the highest level of performance, safety, and efficacy in their practices.

To learn more about Cutera, please visit: https://www.cutera.com.

About Juillet Wellness

Juillet Wellness is a full-service wellness center that offers a convenient and harmonious facility, bringing together a wide range of essential beauty and wellness services under one clinic. With skilled staff and premium products, Juillet Wellness provides a luxurious experience. The wellness center offers various treatments, including registered massage therapy (RMT), physiotherapy, and traditional Chinese medicine through acupuncture, promoting balance and vitality. Juillet Wellness now also offers premium laser treatment services with the addition of CUTERA XEO.

About Justera

Established in 2020, Justera Health Ltd. is a Canadian Company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera’s mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.

For additional information on Justera and other corporate information, please visit the Company’s website at www.justerahealth.com.

For more information about the Company, please refer to the Company’s profile on SEDAR+ at www.sedarplus.ca.

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Investor Relations & Communications

Edward Park, Chief Executive Officer
Tel: (416) 901-5611 x 203
Email: epark@justerahealth.com

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera’s business. Forward-looking information is often, but not always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera’s strategic growth plans, and other factors, many of which are beyond the control of Justera. Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera’s expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

###